Annual Accounts Payable
$240.80 K
-$46.60 K-16.21%
December 1, 2023
Summary
- As of March 10, 2025, XBIO annual accounts payable is $240.80 thousand, with the most recent change of -$46.60 thousand (-16.21%) on December 1, 2023.
- During the last 3 years, XBIO annual accounts payable has fallen by -$86.60 thousand (-26.45%).
- XBIO annual accounts payable is now -86.54% below its all-time high of $1.79 million, reached on December 31, 2015.
Performance
XBIO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$243.30 K
-$40.30 K-14.21%
September 1, 2024
Summary
- As of March 10, 2025, XBIO quarterly accounts payable is $243.30 thousand, with the most recent change of -$40.30 thousand (-14.21%) on September 1, 2024.
- Over the past year, XBIO quarterly accounts payable has stayed the same.
- XBIO quarterly accounts payable is now -88.80% below its all-time high of $2.17 million, reached on September 30, 2016.
Performance
XBIO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
XBIO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.2% | 0.0% |
| 3 y3 years | -26.4% | 0.0% |
| 5 y5 years | -74.2% | 0.0% |
XBIO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.6% | at low | -48.5% | +20.0% |
| 5 y | 5-year | -74.1% | at low | -76.8% | +20.0% |
| alltime | all time | -86.5% | +3154.1% | -88.8% | +216.8% |
Xenetic Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $243.30 K(-14.2%) |
| Jun 2024 | - | $283.60 K(+34.7%) |
| Mar 2024 | - | $210.50 K(-12.6%) |
| Dec 2023 | $240.80 K(-16.2%) | $240.80 K(-46.3%) |
| Sep 2023 | - | $448.60 K(+102.7%) |
| Jun 2023 | - | $221.30 K(-14.6%) |
| Mar 2023 | - | $259.20 K(-9.8%) |
| Dec 2022 | $287.40 K(-20.7%) | $287.40 K(+41.7%) |
| Sep 2022 | - | $202.80 K(-57.1%) |
| Jun 2022 | - | $472.70 K(+68.4%) |
| Mar 2022 | - | $280.70 K(-22.6%) |
| Dec 2021 | $362.50 K(+10.7%) | $362.50 K(+45.9%) |
| Sep 2021 | - | $248.50 K(-18.6%) |
| Jun 2021 | - | $305.10 K(+46.8%) |
| Mar 2021 | - | $207.80 K(-36.5%) |
| Dec 2020 | $327.40 K(-64.8%) | $327.40 K(+30.4%) |
| Sep 2020 | - | $251.00 K(+0.4%) |
| Jun 2020 | - | $250.10 K(-76.2%) |
| Mar 2020 | - | $1.05 M(+12.9%) |
| Dec 2019 | $931.10 K(-0.3%) | $931.10 K(-19.6%) |
| Sep 2019 | - | $1.16 M(+13.2%) |
| Jun 2019 | - | $1.02 M(-1.6%) |
| Mar 2019 | - | $1.04 M(+11.4%) |
| Dec 2018 | $934.10 K(+18.7%) | $934.10 K(+82.2%) |
| Sep 2018 | - | $512.60 K(-31.3%) |
| Jun 2018 | - | $746.50 K(-16.7%) |
| Mar 2018 | - | $896.40 K(+13.9%) |
| Dec 2017 | $786.80 K | $786.80 K(-23.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $1.03 M(+1.3%) |
| Jun 2017 | - | $1.01 M(-26.0%) |
| Mar 2017 | - | $1.37 M(+35.9%) |
| Dec 2016 | $1.01 M(-43.7%) | $1.01 M(-53.6%) |
| Sep 2016 | - | $2.17 M(+7.5%) |
| Jun 2016 | - | $2.02 M(+24.0%) |
| Mar 2016 | - | $1.63 M(-8.9%) |
| Dec 2015 | $1.79 M(+109.7%) | $1.79 M(+20.4%) |
| Sep 2015 | - | $1.48 M(-15.5%) |
| Jun 2015 | - | $1.76 M(+29.2%) |
| Mar 2015 | - | $1.36 M(+59.5%) |
| Dec 2014 | $852.80 K(-9.5%) | $852.80 K(+12.1%) |
| Sep 2014 | - | $761.00 K(+29.0%) |
| Jun 2014 | - | $589.80 K(-0.4%) |
| Mar 2014 | - | $592.40 K(+92.0%) |
| Dec 2013 | $942.20 K(+119.3%) | - |
| Nov 2013 | - | $308.60 K(-28.2%) |
| Aug 2013 | - | $429.70 K(+191.3%) |
| Aug 2013 | $429.70 K(+259.0%) | - |
| May 2013 | - | $147.50 K(+13.2%) |
| Feb 2013 | - | $130.30 K(-43.2%) |
| Dec 2012 | $119.70 K(-37.2%) | - |
| Nov 2012 | - | $229.60 K(+20.4%) |
| Aug 2012 | - | $190.70 K(+46.5%) |
| Aug 2012 | $190.70 K(+2477.0%) | - |
| May 2012 | - | $130.20 K(+69.5%) |
| Feb 2012 | - | $76.80 K |
| Aug 2011 | $7400.00 | - |
FAQ
- What is Xenetic Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Xenetic Biosciences?
- What is Xenetic Biosciences annual accounts payable year-on-year change?
- What is Xenetic Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Xenetic Biosciences?
- What is Xenetic Biosciences quarterly accounts payable year-on-year change?
What is Xenetic Biosciences annual accounts payable?
The current annual accounts payable of XBIO is $240.80 K
What is the all time high annual accounts payable for Xenetic Biosciences?
Xenetic Biosciences all-time high annual accounts payable is $1.79 M
What is Xenetic Biosciences annual accounts payable year-on-year change?
Over the past year, XBIO annual accounts payable has changed by -$46.60 K (-16.21%)
What is Xenetic Biosciences quarterly accounts payable?
The current quarterly accounts payable of XBIO is $243.30 K
What is the all time high quarterly accounts payable for Xenetic Biosciences?
Xenetic Biosciences all-time high quarterly accounts payable is $2.17 M
What is Xenetic Biosciences quarterly accounts payable year-on-year change?
Over the past year, XBIO quarterly accounts payable has changed by $0.00 (0.00%)